Sinovac Biotech (SVA) Files 10M Share Shelf
More News related to SVA
- Sinovac Biotech (SVA) Closes 1.5M Common Offering; Sees $62M Net Proceeds
- Sinovac Announces Closing of Common Share Offering
- Sinovac (SVA) Prices 11.5M Shares at $5.75/Share for Net Proceeds of $62M
- Sinovac Announces Exercise of Over-Allotment Option
- Sinovac Biotech (SVA) Prices 10M Common Offering at $5.75/Share
More News related to Equity Offerings
- Hoku Scientific (HOKU) Files 20.01M Common Shelf for a Selling Shareholder
- China Agritech (CAGC) Files $100M Mixed Securities Shelf
- ChinaTel Group (CHTL) Jumps Higher On 'Above-Market' Equity Financing
- Developers Diversified Realty (DDR) Prices 37.3M Common Offering at $8.16/Share
- EV Energy Partners (EVEP) Prices 3M Common Unit Offering at $28.08/Unit
Sinovac Biotech Ltd. (NYSE: SVA) filed a shelf registration to offer up to 10 million shares of common stock on form F-3 with the SEC.
Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases in China.
Related Categories
Equity OfferingsStocks Mentioned
+0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
